Bristol-Myers Squibb Co (NYSE:BMY), entered into an agreement with CytomX Therapeutics, Inc. BMY announced that the two companies signed worldwide research collaboration and license agreement in order to discover, develop as well as commercialise new therapies against the multiple immuno-oncology targets. This will be done by making use of Probody™ Platform, a proprietary product of CytomX Therapeutics. Bristol-Myers Squibb Co (NYSE:BMY), net profit margin is 17.70% and weekly performance is -5.01%. On last trading day company shares ended up $47.25. Analysts mean target price for the company is $54.76. Bristol-Myers Squibb Co (NYSE:BMY), distance from 50-day simple moving average (SMA50) is -5.44%.
Merck & Co., Inc. (NYSE:MRK), health care company is engaged in providing medical solutions as medicines, vaccines and biologic therapies. Merck & Co. has recently announced that its new immunotherapy has produced positive results in patients suffering from advanced melanoma. Merck & Co., Inc. (NYSE:MRK), advanced 0.43% in last trading session and ended the day on $57.85. MRK, Gross Margin is 58.50% and its return on assets is 5.70%. Merck & Co., Inc. (NYSE:MRK), quarterly performance is 1.46%.
Pfizer Inc. (NYSE:PFE), Insider Geno J. Germano sold 30,000 shares of the company’s stock on the open market in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $29.68, for a total value of $890,400.00. Following the completion of the transaction, the insider now directly owns 263,495 shares of the company’s stock, valued at approximately $7,820,532. Pfizer Inc. (NYSE:PFE), shares moved down 1.14% in last trading session and was closed at $29.42, while trading in range of $29.34 – 29.87. Pfizer Inc. (NYSE:PFE), year to date (YTD) performance is -2.29%.
Abbott Laboratories (NYSE:ABT), and AbbVie Inc. will face lawsuits combined in one Chicago court over claims they hid the risks of using the testosterone-replacement drug AndroGel. Abbott Laboratories (NYSE:ABT), ended the last trading day at $40.05. Company weekly volatility is calculated as 0.90% and price to cash ratio as 8.54. Abbott Laboratories (NYSE:ABT), showed a negative weekly performance of 0.10%.
Germany’s Bayer AG (ADR) (OTCMKTS:BAYRY), said Dieter Weinand, 53, would become President of Bayer HealthCare Pharmaceuticals, effective August 1, and at the same time join the Executive Committee of Bayer HealthCare. Bayer AG (ADR) (OTCMKTS:BAYRY), on last trading day company shares ended up $143.51.